Toxicogenetic evaluation of metronidazole in the treatment of women infected with Trichomonas vaginalis
Samples of peripheral blood were collected once from non-smoking women who were healthy (controls) and twice (immediately before and immediately after 7 days of treatment with metronidazole at 500 mg/day) from non-smoking women infected with Trichomonas vaginalis. Lymphocyte cultures were prepared a...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2004
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12046caa a22012497a 4500 | ||
|---|---|---|---|
| 001 | PAPER-4656 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203414.0 | ||
| 008 | 190411s2004 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-1642369560 | |
| 024 | 7 | |2 cas |a metronidazole, 39322-38-8, 443-48-1; Antitrichomonal Agents; Metronidazole, 443-48-1 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a ATMPA | ||
| 100 | 1 | |a Carballo, M.A. | |
| 245 | 1 | 0 | |a Toxicogenetic evaluation of metronidazole in the treatment of women infected with Trichomonas vaginalis |
| 260 | |c 2004 | ||
| 270 | 1 | 0 | |m Carballo, M.A.; Citogenetica y Genet. Toxicologica, Depto. de Bioquim. Clin., Universidad de Buenos Aires, Junín 956, (1113), Buenos Aires, Argentina; email: macarballo@dbc.ffyb.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Monographs on the evaluation of carcinogenic risks to humans (1987) Genetic and Related Effects: An Updating of Selected IARC Monographs, pp. 399-402. , Lyon, France: International Agency for Research on Cancer | ||
| 504 | |a (1997) Monographs on the Evaluation of Carcinogenic Risks to Humans. List of IARC Evaluations, , Lyon, France: International Agency for Research on Cancer | ||
| 504 | |a Brezden, C., Horn, L., McClelland, R., Rauth, A., Oxidative stress and 1-methyl-2-nitroimidazole cytotoxicity (1998) Biochemical Pharmacology, 56, pp. 335-344 | ||
| 504 | |a Burgess, D.E., Trichomonads and intestinal flagellates (1998) Microbiology and Microbial Infections, pp. 203-214. , eds Cox, F. E. G., Kreier, J. P. & Wakelin, D. New York: Oxford University Press | ||
| 504 | |a Carballo, M.A., Alvarez, S., Boveris, A., Cellular stress by light and Rose Bengal in human lymphocytes (1994) Mutation Research, 288, pp. 215-222 | ||
| 504 | |a Chacko, M., Bhide, S.V., Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice (1986) Journal of Cancer Research, 112, pp. 135-140 | ||
| 504 | |a Connor, T.H., Stoeckel, M., Evrard, J., Legator, M.S., The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice (1977) Cancer Research, 37, pp. 629-633 | ||
| 504 | |a Dayan, J., Crajer, M.C., Deguingaund, S., Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells (1982) Mutation Research, 102, pp. 1-12 | ||
| 504 | |a De Meo, M., Vanelle, P., Bernardi, E., Laget, M., Maldonado, J., Jentzer, O., Crozet, M.P., Dumenil, G., Evaluation on mutagenic and genotoxic activities of 48 nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest (1992) Environmental and Molecular Mutagenesis, 19, pp. 167-170 | ||
| 504 | |a Delcenserie, R., Yzet, T., Ducroix, J.P., Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis (1996) Pancreas, 13, pp. 180-201 | ||
| 504 | |a Dobías, L., Cerna, M., Rossner, P., Sram, R., Genotoxicity and carcinogenicity of metronidazole (1994) Mutation Research, 317, pp. 177-194 | ||
| 504 | |a Elizondo, G., Montero, R., Herrera, J.E., Hong, E., Ostrosky-Wegman, P., Lymphocyte proliferation kinetics and sister-chromatid exchanges in individuals treated with metronidazole (1994) Mutation Research, 305, pp. 133-137 | ||
| 504 | |a Freeman, C.D., Klutman, N.E., Lamp, K.C., Metronidazole - A therapeutic review and update (1997) Drugs, 54, pp. 679-708 | ||
| 504 | |a Gentile, J.M., Gentile, G., Nannenga, B., Johnson, M., Blankespoor, H., Montero, R., Enhanced liver cell mutations in trematode-infected Big Blue® transgenic mice (1998) Mutation Research, 400, pp. 355-360 | ||
| 504 | |a Haisfield-Wolfe, M.E., Rund, C., Malignant cutaneous wounds: A management protocol (1997) Ostomy Wound Management, 43, pp. 56-64 | ||
| 504 | |a Herrera, L.A., Montero, R., León-Cázares, J.M., Rojas, E., Gonsebatt, M.E., Ostrosky-Wegman, P., Effects of progesterone and estradiol on the proliferation of phytohemagglutinin-stimulated human lymphocytes (1992) Mutation Research, 270, pp. 211-218 | ||
| 504 | |a Ivett, J.L., Tice, R.R., Average generation time: A new method of analysis and quantitation of cellular proliferation kinetics (1982) Environmental Mutagenesis, 4, p. 358 | ||
| 504 | |a Kierszenbaum, F., Cuna, W.R., Beltz, L.A., Sztein, M.B., Trypanosomal inmunosuppresive factor: A secretion product(s) of Trypanosome cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells (1990) Journal of Immunology, 144, pp. 4000-4004 | ||
| 504 | |a Kulda, J., Trichomonads, hydrogenosomes and drug resistance (1999) International Journal for Parasitology, 29, pp. 199-212 | ||
| 504 | |a Lambert, B., Linbland, A., Sister chromatid exchange and chromosomal aberrations in lymphocytes of laboratory personal (1980) Journal of Toxicology and Environmental Health, 6, pp. 1237-1243 | ||
| 504 | |a Lambert, B., Sten, M., Hellgren, D., Removal and persistence of SCE-inducing damage in human lymphocytes in vitro (1984) Basic Life Sciences, 29 B, pp. 647-662 | ||
| 504 | |a Lamp, K.C., Freeman, C.D., Klutman, N.E., Lacy, M.K., Pharmacokinetics and pharmacodynamics of the nitroirnidazole antimicrobials (1999) Clinical Pharrmacokinetics, 36, pp. 353-375 | ||
| 504 | |a López Nigro, M., Palermo, A.M., Mudry, M.D., Carballo, M.A., Cytogenetic evaluation of two nitroimidazole derivatives (2003) Toxicology in Vitro, 17, pp. 35-110 | ||
| 504 | |a Ludlum, D.B., Colinas, R.J., Kirk, M.C., Mehta, J.R., Reaction of reduced Metronidazole with guanosine to form an unstable adduct (1988) Carcinogenesis, 9, pp. 593-596 | ||
| 504 | |a Mahood, J.S., Wilson, R.L., Failure to induce sister chromatid exchanges (SCE) with metronidazole (1981) Toxicology Letters, 8, pp. 359-361 | ||
| 504 | |a Martelli, A., Allavena, A., Robbiano, L., Mattioli, F., Brambilla, G., Comparison of sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole (1990) Pharmacology and Toxicology, 66, pp. 329-334 | ||
| 504 | |a Motorna, O.O., Martin, H., Gentile, G.J., Gentile, J.M., Analysis of lacI mutations in Big Blue® transgenic mice subjected to parasite-induced inflammation (2001) Fundamental and Molecular Mechanisms of Mutagenesis, 484, pp. 69-76 | ||
| 504 | |a Mudry, M.D., Carballo, M.A., De Labal Vinuesa, M., Larripa, I., Mutagenic bioassays of certain pharmacological drugs. III. Metronidazole (MTZ) (1994) Mutation Research, 305, pp. 127-132 | ||
| 504 | |a Mudry, M.D., Gadano, A., González, M., Carballo, M.A., Mutagénesis química: Riesgo y beneficio en el consumo de antiparasitarios (1995) Interciencia, 20, pp. 204-211 | ||
| 504 | |a Mudry, M.D., Martínez-Flores, I., Palermo, A.M., Carballo, M.A., Egozcue, J., García Caldés, M., Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus (2001) Teratogenesis, Carcinogenesis and Mutagenesis, 21, pp. 197-205 | ||
| 504 | |a Munoz, E., Castella, J., Gutiérrez, J.F., In vivo and in vitro sensitivity of Trichomonas gallinae to some nitroimidazole drugs (1998) Veterinarian Parasitology, 78, pp. 239-246 | ||
| 504 | |a Neal, S.B., Probst, G.S., Chemically-induced sister chromatid exchange in vivo in bone marrow of Chinese hamster. An evaluation of 24 compounds (1983) Mutation Research, 113, pp. 33-43 | ||
| 504 | |a Perry, P., Wolff, S., New Giemsa method for differential staining of sister chromatids (1974) Nature, 261, pp. 156-161 | ||
| 504 | |a Qasim, A., O'Morain, C.A., Treatment of Helicobacter pylori infection and factors influencing eradication (2002) Alimentary Pharmacology and Therapeutics, 16, pp. 24-30 | ||
| 504 | |a Rodriguez Ferreiro, G., Cancino Badías, L., López Nigro, M., Palermo, A., Mudry, M., Prieto González, E., Carballo, M.A., DNA single strand breaks in peripheral lymphocytes induced by three nitroimidazole derivatives (2002) Toxicology Letters, 132, pp. 109-115 | ||
| 504 | |a Rustia, M., Shubik, P., Induction of lung tumours and malignant lymphomas in mice by metronidazole (1972) Journal of the National Cancer Institute, 48, pp. 721-729 | ||
| 504 | |a Saavedra Lira, E., Perez Montfort, R., Energy production in Entamoeba histolytica - New perspectives in rational drug design (1996) Archives of Medical Research, 27, pp. 257-264 | ||
| 504 | |a Swenson, D.H., Harbach, P.R., Trzos, R.J., The relationship between alkylations of specific DNA bases and induction of sister chromatid exchanges (1980) Carcinogenesis, 1, pp. 931-936 | ||
| 520 | 3 | |a Samples of peripheral blood were collected once from non-smoking women who were healthy (controls) and twice (immediately before and immediately after 7 days of treatment with metronidazole at 500 mg/day) from non-smoking women infected with Trichomonas vaginalis. Lymphocyte cultures were prepared and used, in toxicogenetic studies, to determine the frequency of sister-chromatid exchange (SCE), the mitotic index (MI), and the replication index (RI) for each sample. MTZ treatment of the infected women led to an increase in the frequency of SCE (P < 0.001), a decrease in the MI (P < 0.003), and a modification in the kinetics of cell proliferation, with a decrease in the RI (P < 0.0006). The differences seen between the results for the controls and those for the infected women, before and after MTZ treatment, may be attributed to the presence of the parasite, to the treatment itself, and/or to variation in the host's response to infection with T. vaginalis. |l eng | |
| 593 | |a Citogenetica y Genet. Toxicologica, Depto. de Bioquim. Clin., Universidad de Buenos Aires, Junín 956, (1113), Buenos Aires, Argentina | ||
| 593 | |a Inst. Invest. Cie. Tec. de las FFAA, Juan Bautista de la Salle 4397, (1603), Buenos Aires, Argentina | ||
| 593 | |a Grupo de Invest. en Biol. Evolutiva, Depto. de Ecologia, Genet. y Evol., Pabellón 2, Lab. 46-47, (C1428EHA), Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a METRONIDAZOLE |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a BLOOD SAMPLING |
| 690 | 1 | 0 | |a CELL DIVISION |
| 690 | 1 | 0 | |a CLINICAL ARTICLE |
| 690 | 1 | 0 | |a CLINICAL TRIAL |
| 690 | 1 | 0 | |a CONFIDENCE INTERVAL |
| 690 | 1 | 0 | |a CONTROLLED CLINICAL TRIAL |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DRUG EFFECT |
| 690 | 1 | 0 | |a DRUG SCREENING |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a GENOTOXICITY |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a IMMUNE RESPONSE |
| 690 | 1 | 0 | |a LYMPHOCYTE CULTURE |
| 690 | 1 | 0 | |a LYMPHOCYTE PROLIFERATION |
| 690 | 1 | 0 | |a MITOSIS INDEX |
| 690 | 1 | 0 | |a PARAMETER |
| 690 | 1 | 0 | |a SISTER CHROMATID EXCHANGE |
| 690 | 1 | 0 | |a TRICHOMONAS VAGINALIS |
| 690 | 1 | 0 | |a TRICHOMONIASIS |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a ANTITRICHOMONAL AGENTS |
| 690 | 1 | 0 | |a CELL DIVISION |
| 690 | 1 | 0 | |a CELLS, CULTURED |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a LYMPHOCYTES |
| 690 | 1 | 0 | |a METRONIDAZOLE |
| 690 | 1 | 0 | |a MITOTIC INDEX |
| 690 | 1 | 0 | |a SISTER CHROMATID EXCHANGE |
| 690 | 1 | 0 | |a TRICHOMONAS VAGINITIS |
| 690 | 1 | 0 | |a PROTOZOA |
| 690 | 1 | 0 | |a TRICHOMONAS VAGINALIS |
| 700 | 1 | |a Palermo, A.M. | |
| 700 | 1 | |a Mudry, M.D. | |
| 773 | 0 | |d 2004 |g v. 98 |h pp. 139-147 |k n. 2 |p Ann. Trop. Med. Parasitol. |x 00034983 |w (AR-BaUEN)CENRE-3707 |t Annals of Tropical Medicine and Parasitology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642369560&doi=10.1179%2f000349804225003109&partnerID=40&md5=01729eb1a4df340f394e66f7eb7f470e |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1179/000349804225003109 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00034983_v98_n2_p139_Carballo |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00034983_v98_n2_p139_Carballo |y Registro en la Biblioteca Digital |
| 961 | |a paper_00034983_v98_n2_p139_Carballo |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 65609 | ||